Impact of systolic blood pressure on hemorrhagic stroke in patients with coronary artery disease during anti-platelet therapy: The Japanese Coronary Artery Disease (JCAD) study

被引：9

作者：

Kai, Hisashi ^{[1
]}

Kohro, Takahide ^{[2
]}

Fukuda, Kenji ^{[3
]}

Yamazaki, Tsutomu ^{[4
]}

Nagai, Ryozo ^{[5
]}

机构：

[1] Kurume Univ, Med Ctr, Dept Cardiol, 155-1 Kokubu Machi, Kurume, Fukuoka 8390863, Japan

[2] Jichi Med Univ, Dept Clin Informat, Shimotsuke, Tochigi, Japan

[3] St Marys Hosp, Dept Cerebrovasc Med, Kurume, Fukuoka, Japan

[4] Tokyo Univ Hosp, Clin Res Support Ctr, Tokyo, Japan

[5] Jichi Med Univ, Shimotsuke, Tochigi, Japan

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 224卷

关键词：

Anti-platelet therapy; Coronary artery disease; Hypertension; Stroke; Warfarin; ANTITHROMBOTIC THERAPY; ATRIAL-FIBRILLATION; BLEEDING EVENTS; RISK;

D O I：

10.1016/j.ijcard.2016.09.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：112 / 113

页数：2

共 9 条

[1] Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy The PROGRESS Trial [J].

Arima, Hisatomi ;

Anderson, Craig ;

Omae, Teruo ;

Woodward, Mark ;

MacMahon, Stephen ;

Mancia, Giuseppe ;

Bousser, Marie-Germaine ;

Tzourio, Christophe ;

Rodgers, Anthony ;

Neal, Bruce ;

Chalmers, John .

STROKE, 2012, 43 (06) :1675-1677

[2] Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial [J].

Diener, HC ;

Bogousslavsky, J ;

Brass, LM ;

Cimminiello, C ;

Csiba, L ;

Kaste, M ;

Leys, D ;

Matias-Guiv, J ;

Rupprecht, HJ .

LANCET, 2004, 364 (9431) :331-337

[3]

Japanese Coronary Artery Disease (JCAD) Study Investigators, 2006, Circ J, V70, P1256

[4]

Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007

[5] Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis [J].

Menozzi M. ;

Rubboli A. ;

Manari A. ;

De Palma R. ;

Grilli R. .

Thrombosis Journal, 10 (1)

[6] A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey [J].

Pisters, Ron ;

Lane, Deirdre A. ;

Nieuwlaat, Robby ;

de Vos, Cees B. ;

Crijns, Harry J. G. M. ;

Lip, Gregory Y. H. .

CHEST, 2010, 138 (05) :1093-1100

[7] Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease - A prospective, multicenter, observational study [J].

Toyoda, Kazunori ;

Yasaka, Masahiro ;

Iwade, Kazunori ;

Nagata, Ken ;

Koretsune, Yukihiro ;

Sakamoto, Tomohiro ;

Uchiyama, Shinichiro ;

Gotoh, Jun ;

Nagao, Takehiko ;

Yamamoto, Masahiro ;

Takahashi, Jun C. ;

Minematsu, Kazuo .

STROKE, 2008, 39 (06) :1740-1745

[8] Blood Pressure Levels and Bleeding Events During Antithrombotic Therapy The Bleeding With Antithrombotic Therapy (BAT) Study [J].